NIH Funding Opportunities (Notices, PA, RFA)

Weekly Funding Opportunities and Policy Notices from the National Institutes of Health.
Updated: 1 hour 13 min ago
Notice of Change: Extension of PAR-22-030 "Translational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neuromuscular Disorders (U01 - Clinical Trial Optional)" by one Council Round
Notice NOT-NS-24-020 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Addressing Health and Health Care Disparities among Sexual and Gender Minority Populations (R01 - Clinical Trials Optional)
Funding Opportunity PAR-24-077 from the NIH Guide for Grants and Contracts. The purpose of this Notice of Funding Opportunity (NOFO) is to support innovative observational and intervention-based research to identify and characterize the pathways and mechanisms through which health and health care disparities occur among sexual and gender minority populations of minoritized racial/ethnic and socio-economic statuses.
Categories: Job Watch, Literature Watch
Notice of Change: Extension of PAR-22-028 "Ultra-Rare Gene-based Therapy (URGenT) Network Resource Access (X01, Clinical Trial Not Allowed)" by one Council Round
Notice NOT-NS-24-035 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Change: Extension of PAR-21-224 "NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional)"
Notice NOT-NS-24-037 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of NHLBI Participation in NOT-EY-23-009 "Notice of Special Interest (NOSI): Quantum Sensing in Biomedical Applications (SBIR/STTR)"
Notice NOT-HL-23-121 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Change to Key Dates Listed in RFA-AG-24-030, "Consortium for Economic Research on AD/ADRD Prevention, Treatment, and Care Coordinating Center (U54 Clinical Trial Optional)"
Notice NOT-AG-23-074 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Short-Term Research Education Program to Enhance Diversity in Health-Related Research (R25 Clinical Trial Not Allowed)
Funding Opportunity RFA-HL-25-001 from the NIH Guide for Grants and Contracts. The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this NHLBI R25 program is to support educational activities that enhance the diversity of the biomedical, behavioral and clinical research workforce by providing research experiences and related opportunities that enrich the pool of individuals from nationally underrepresented groups who will be available to compete for research opportunities in the mission areas of importance to NHLBI. To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on Research Experiences.
Categories: Job Watch, Literature Watch
Addressing the Impact of Syndemics on the Health of People with HIV and Diseases and Conditions within the Missions of NIDDK and NHLBI (R01 Clinical Trial Optional)
Funding Opportunity RFA-DK-25-001 from the NIH Guide for Grants and Contracts. Addressing the Impact of Syndemics on the Health of People with HIV and Diseases and Conditions within the Missions of NIDDK and NHLBI (R01 Clinical Trial Optional)
Categories: Job Watch, Literature Watch
Cardiovascular Repository Type 1 Diabetes (CARE-T1D) Consortium (U01 Clinical Trial Not Allowed).
Funding Opportunity RFA-DK-23-021 from the NIH Guide for Grants and Contracts. Cardiovascular complications are the leading cause of death for individuals with type 1 diabetes (T1D) and significantly shorten their lives. Cardiovascular disease (CVD) progression in people with T1D differs from that observed in people with type 2 diabetes (T2D) and residual increased risk of CVD remains after treatment of standard risk factors, such as hyperglycemia, hypertension, and hyperlipidemia. The NIH Cardiovascular Repository for T1D (CaRe-T1D) was initiated with the goal of establishing a biorepository of human CV tissue and a scientific consortium to advance and support discovery and mechanistic research that increase the understanding of CVD in T1D. The first phase launched the biorepository and now in the second phase investigative teams will be added to form a consortium with the biorepository serving as the Coordinating Center (CC). CaRe-T1D is currently collecting hearts, kidneys, carotid and peripheral arteries, and blood from organ donors with T1D, T2D and without diabetes. The goal of this NOFO is to attract investigative teams with complementary interests and expertise who will leverage these resources through individual and collaborative studies to advance our knowledge of the pathogenesis of CVD in T1D.
Categories: Job Watch, Literature Watch
Alcohol Research-Related Resource Award (R24 Clinical Trial Not Allowed)
Funding Opportunity PAR-24-071 from the NIH Guide for Grants and Contracts. The purpose of the Resource-Related Research Projects (R24) grant is to support investigator-initiated resources designed to provide materials and services to support and advance biomedical research on a national basis. An R24 resource grant mechanism is a non-hypothesis-driven activity to provide data, materials, tools, or services that are essential to making timely, high quality, and cost-efficient progress in a field. Hypothesis-driven research applications should not be submitted in response to this program announcement but to another mechanism that encourages this type of research. The resource should be available to any qualified investigator, and should be highly quality controlled, and not duplicate resources available commercially or through other sources. Resources should be designed to provide services to the broad alcohol research community and should not be limited by any specific regional focus.
Categories: Job Watch, Literature Watch
Notice of Change to Key Dates for PAR-23-308, Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) (U54 Clinical Trial Optional)
Notice NOT-CA-24-011 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Request for Information on Themes for the NIAMS Strategic Plan for Fiscal Years 2025-2029
Notice NOT-AR-23-022 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Pre-Application Webinar for NOT-AG-23-060, "Notice of Special Interest (NOSI): Telehealth for People and Families Living with Alzheimer's Disease (AD) and AD-Related Dementias (ADRD)"
Notice NOT-AG-23-073 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Intent to Publish a Funding Opportunity Announcement for Open Measurement Coordinating Network for Non-Pharmacological Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) Primary Prevention Trials (U24 Clinical Trial Optional)
Notice NOT-AG-23-061 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Extension of the Expiration Date for PAR-21-290 "Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)"
Notice NOT-CA-24-012 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Providing Research Education Experiences to Enhance Inclusivity for a Diverse Substance Use and Addiction Scientific Workforce (R25 Clinical Trials Not Allowed)
Funding Opportunity PAR-24-048 from the NIH Guide for Grants and Contracts. The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this R25 program is to support educational activities that encourage individuals from diverse backgrounds, including those from groups underrepresented in the biomedical and behavioral sciences, to pursue further studies or careers in research.
Categories: Job Watch, Literature Watch
Resources to Promote Coordination and Collaboration across Deeply Phenotyped Longitudinal Behavioral and Social Studies of Aging (U24 Clinical Trial Not Allowed)
Funding Opportunity RFA-AG-25-006 from the NIH Guide for Grants and Contracts. This Notice of Funding Opportunity (NOFO) invites applications to establish a Resource Development Network (RDN) focused on the infrastructure needed to promote and support coordination, collaboration, and innovation across deeply phenotyped longitudinal behavioral and social studies of aging. This NOFO calls for investigator teams to design an innovative network that will serve the field at large and advance collaboration and coordination among studies. RDN activities must include: The creation of a publicly-available meta-data catalog on a web-based platform that will identify and describe existing small- to mid-size deeply phenotyped longitudinal studies designed to investigate factors affecting health and well-being in later life and characterized by rich psychological, social, behavioral, and biobehavioral content; outreach to investigators that will stimulate innovation, collaboration, dissemination, and utilization of the meta-data catalog and associated datasets; methodological consultation services for investigators interested in data harmonization projects and/or coordinated data analysis with deeply phenotyped longitudinal studies; and support for next generation trainees and early career investigators to initiate data harmonization and/or coordinated data-analysis projects utilizing deeply phenotyped longitudinal studies to answer questions relevant to aging and the adult lifespan.
Categories: Job Watch, Literature Watch
Notice of Information: NIMH List of Human Genes Having Rare Variants with Strong Statistical Support for Association to Mental Health Traits
Notice NOT-MH-24-370 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
Funding Opportunity RFA-CA-24-009 from the NIH Guide for Grants and Contracts. This Notice of Funding Opportunity (NOFO) solicits grant applications proposing exploratory research projects focused on further development and validation of emerging technologies offering novel capabilities for targeting, probing, or assessing molecular and cellular features of cancer biology for basic or clinical cancer research. This NOFO solicits R33 applications where major feasibility gaps for the technology or methodology have been overcome, as demonstrated with supportive preliminary data, but still requires further development and rigorous validation to encourage adoption by the research community. Well-suited applications must offer the potential to accelerate and/or enhance research in the areas of cancer biology, early detection and screening, clinical diagnosis, treatment, control, epidemiology, and/or address issues associated with cancer health disparities. Technologies proposed for development may be intended to have widespread applicability but must be focused on improving molecular and/or cellular characterizations of cancer. Projects proposing application of existing technologies where the novelty resides in the biological or clinical target/question being pursued are not appropriate for this solicitation and will not be reviewed. This funding opportunity is part of a broader NCI-sponsored Innovative Molecular Analysis Technologies (IMAT) Program.
Categories: Job Watch, Literature Watch
Notice of Special Interest (NOSI): SBIR/STTR Program Priorities to Bridge Gaps in Advancing the NIMH Mission
Notice NOT-MH-24-110 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch